Profiling of different pancreatic cancer cells used as models for metastatic behaviour shows large variation in their N-glycosylation

[1]  F. Q. Ribeiro.  The meta-analysis , 2017, Brazilian journal of otorhinolaryngology.

[2]  N. Packer,et al.  Emerging roles of protein mannosylation in inflammation and infection. , 2016, Molecular aspects of medicine.

[3]  Matthew S Macauley,et al.  Targeting Selectins and Their Ligands in Cancer , 2016, Front. Oncol..

[4]  Ana Magalhães,et al.  Glycomic Approaches for the Discovery of Targets in Gastrointestinal Cancer , 2016, Front. Oncol..

[5]  R. Gibbs,et al.  Genomic analyses identify molecular subtypes of pancreatic cancer , 2016, Nature.

[6]  N. Nonomura,et al.  Site-specific and linkage analyses of fucosylated N-glycans on haptoglobin in sera of patients with various types of cancer: possible implication for the differential diagnosis of cancer , 2016, Glycoconjugate Journal.

[7]  Manfred Wuhrer,et al.  N-glycosylation Profiling of Colorectal Cancer Cell Lines Reveals Association of Fucosylation with Differentiation and Caudal Type Homebox 1 (CDX1)/Villin mRNA Expression* , 2016, Molecular & Cellular Proteomics.

[8]  Magnus Palmblad,et al.  MassyTools: A High-Throughput Targeted Data Processing Tool for Relative Quantitation and Quality Control Developed for Glycomic and Glycoproteomic MALDI-MS. , 2015, Journal of proteome research.

[9]  Young Hwan Kim,et al.  Mass spectrometry-based N-linked glycomic profiling as a means for tracking pancreatic cancer metastasis. , 2015, Carbohydrate research.

[10]  P. Koolwijk,et al.  Hypoxia inducible factor 1α down regulates cell surface expression of α1,2‐fucosylated glycans in human pancreatic adenocarcinoma cells , 2015, FEBS letters.

[11]  Honghe Zhang,et al.  Tumor markers CA19-9, CA242 and CEA in the diagnosis of pancreatic cancer: a meta-analysis. , 2015, International journal of clinical and experimental medicine.

[12]  Y. Mechref,et al.  N-linked glycan profiling in neuroblastoma cell lines. , 2015, Journal of proteome research.

[13]  E. Miyoshi,et al.  Fucosylation is a common glycosylation type in pancreatic cancer stem cell-like phenotypes. , 2015, World journal of gastroenterology.

[14]  Daniel Reitz,et al.  Combination of tumour markers CEA and CA19-9 improves the prognostic prediction in patients with pancreatic cancer , 2015, Journal of Clinical Pathology.

[15]  R. Christopherson,et al.  Comprehensive glycomics comparison between colon cancer cell cultures and tumours: implications for biomarker studies. , 2014, Journal of proteomics.

[16]  E. Giovannetti,et al.  Galectin-4 expression is associated with reduced lymph node metastasis and modulation of Wnt/β-catenin signalling in pancreatic adenocarcinoma , 2014, Oncotarget.

[17]  Sandra Carvalho,et al.  Pancreatic Cancer Cell Glycosylation Regulates Cell Adhesion and Invasion through the Modulation of α2β1 Integrin and E-Cadherin Function , 2014, PloS one.

[18]  André M Deelder,et al.  High-throughput profiling of protein N-glycosylation by MALDI-TOF-MS employing linkage-specific sialic acid esterification. , 2014, Analytical chemistry.

[19]  Mack T. Ruffin,et al.  Glycoprotein Biomarker Panel for Pancreatic Cancer Discovered by Quantitative Proteomics Analysis , 2014, Journal of proteome research.

[20]  A. Horii,et al.  Molecular pathology of pancreatic cancer , 2014, Pathology international.

[21]  E. Giovannetti,et al.  Crizotinib inhibits metabolic inactivation of gemcitabine in c-Met-driven pancreatic carcinoma. , 2013, Cancer research.

[22]  M. Matin,et al.  Immortality of cell lines: challenges and advantages of establishment , 2013, Cell biology international.

[23]  R. Peracaula,et al.  α2,3-Sialyltransferase ST3Gal IV promotes migration and metastasis in pancreatic adenocarcinoma cells and tends to be highly expressed in pancreatic adenocarcinoma tissues. , 2013, The international journal of biochemistry & cell biology.

[24]  A. M. van der Sar,et al.  Galectin-4 Reduces Migration and Metastasis Formation of Pancreatic Cancer Cells , 2013, PloS one.

[25]  E. Miyoshi,et al.  Fucosylated haptoglobin is a novel type of cancer biomarker linked to the prognosis after an operation in colorectal cancer , 2012, Cancer.

[26]  Bond-Smith Giles,et al.  Only women with symptoms need to have their breast implants removed, says government , 2012 .

[27]  Eva Negri,et al.  Pancreatic cancer: Overview of descriptive epidemiology , 2012, Molecular carcinogenesis.

[28]  Y. Jeng,et al.  B4GALNT3 expression predicts a favorable prognosis and suppresses cell migration and invasion via β₁ integrin signaling in neuroblastoma. , 2011, The American journal of pathology.

[29]  Manfred Wuhrer,et al.  Mass spectrometric glycan rearrangements. , 2011, Mass spectrometry reviews.

[30]  E. Steenvoorden,et al.  2‐Picoline‐borane: A non‐toxic reducing agent for oligosaccharide labeling by reductive amination , 2010, Proteomics.

[31]  Maria Blomqvist,et al.  Analysis of the human cancer glycome identifies a novel group of tumor-associated N-acetylglucosamine glycan antigens. , 2009, Cancer research.

[32]  R. Cummings,et al.  The N-glycolyl form of mouse sialyl Lewis X is recognized by selectins but not by HECA-452 and FH6 antibodies that were raised against human cells , 2009, Glycoconjugate Journal.

[33]  M. Lerch,et al.  Metastatic behaviour of primary human tumours in a zebrafish xenotransplantation model , 2009, BMC Cancer.

[34]  G. Feldmann,et al.  In vitro models of pancreatic cancer for translational oncology research , 2009, Expert opinion on drug discovery.

[35]  Michelle A. Anderson,et al.  Pancreatic cancer serum detection using a lectin/glyco-antibody array method. , 2009, Journal of proteome research.

[36]  Martin Strohalm,et al.  mMass data miner: an open source alternative for mass spectrometric data analysis. , 2008, Rapid communications in mass spectrometry : RCM.

[37]  P. Pour,et al.  Immortalization with telomerase of the Nestin-positive cells of the human pancreas. , 2003, Biochemical and biophysical research communications.

[38]  A. Cooperman.  Pancreatic cancer: the bigger picture. , 2001, The Surgical clinics of North America.

[39]  R. Cummings,et al.  Antibody responses to the fucosylated LacdiNAc glycan antigen in Schistosoma mansoni-infected mice and expression of the glycan among schistosomes. , 2000, Experimental parasitology.

[40]  M. Aubert,et al.  Restoration of alpha(1,2) fucosyltransferase activity decreases adhesive and metastatic properties of human pancreatic cancer cells. , 2000, Cancer research.

[41]  R. Kannagi,et al.  Altered mRNA expression of specific molecular species of fucosyl‐ and sialyl‐transferases in human colorectal cancer tissues , 1997, International journal of cancer.

[42]  H. Cooper,et al.  Elevated expression of H type GDP-L-fucose:beta-D-galactoside alpha-2-L-fucosyltransferase is associated with human colon adenocarcinoma progression. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[43]  T. Okai,et al.  Expression of Various Sialylated Carbohydrate Antigens in Malignant and Nonmalignant Pancreatic Tissues , 1991, Pancreas.

[44]  Y. Chung,et al.  Lex and Ley antigen expression in human pancreatic cancer. , 1988, Cancer research.

[45]  H. Kocher,et al.  Pancreatic Cancer , 2019, Methods in Molecular Biology.

[46]  A. Jemal,et al.  Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.

[47]  Honghe Zhang,et al.  Tumor markers CA 19-9 , CA 242 and CEA in the diagnosis of pancreatic cancer : a meta-analysis , 2015 .

[48]  Y. Rombouts,et al.  Glycosylation characteristics of colorectal cancer. , 2015, Advances in cancer research.

[49]  J.,et al.  The New England Journal of Medicine , 2012 .

[50]  Laura H. Tang,et al.  Survival after Resection of Pancreatic Adenocarcinoma: Results from a Single Institution over Three Decades , 2011, Annals of Surgical Oncology.

[51]  Tom Vink,et al.  N‐linked glycosylation is an important parameter for optimal selection of cell lines producing biopharmaceutical human IgG , 2009, Biotechnology progress.

[52]  R. Devlin.  A bigger picture , 2008, Nature.

[53]  Jin-Tung Liang,et al.  Beta1,4-N-acetylgalactosaminyltransferase III enhances malignant phenotypes of colon cancer cells. , 2007, Molecular cancer research : MCR.

[54]  M. Ouellette,et al.  Use of exogenous hTERT to immortalize primary human cells , 2004, Cytotechnology.

[55]  H. Elsässer,et al.  Establishment and characterisation of two cell lines with different grade of differentiation derived from one primary human pancreatic adenocarcinoma , 1992, Virchows Archiv. B, Cell pathology including molecular pathology.

[56]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.